Low-Dose Anticoagulation to Prevent Intracranial Hemorrhage in COVID-19 Patients under Extracorporeal Membrane Oxygenation Support

Am J Respir Crit Care Med. 2024 Apr 1;209(7):894-895. doi: 10.1164/rccm.202311-2090LE.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anticoagulants / adverse effects
  • Blood Coagulation
  • COVID-19*
  • Extracorporeal Membrane Oxygenation*
  • Heparin / pharmacology
  • Humans
  • Intracranial Hemorrhages / chemically induced
  • Retrospective Studies

Substances

  • Anticoagulants
  • Heparin